DSpace Repository

Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?

Show simple item record

dc.contributor.author Yildiz, Elif
dc.contributor.author Timur, Burcu
dc.contributor.author Guney, Gurhan
dc.contributor.author Timur, Hakan
dc.date.accessioned 2024-03-25T06:19:14Z
dc.date.available 2024-03-25T06:19:14Z
dc.date.issued 2023
dc.identifier.citation Yildiz, E., Timur, B., Guney, G., Timur, H. (2023). Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?. Medicine (Baltimore), 102(20). https://doi.org/10.1097/MD.0000000000033824 en_US
dc.identifier.issn 0025-7974
dc.identifier.issn 1536-5964
dc.identifier.uri http://dx.doi.org/10.1097/MD.0000000000033824
dc.identifier.uri https://www.webofscience.com/wos/woscc/full-record/WOS:000995227300025
dc.identifier.uri http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4956
dc.description WoS Categories: Medicine, General & Internal en_US
dc.description Web of Science Index: Science Citation Index Expanded (SCI-EXPANDED) en_US
dc.description Research Areas: General & Internal Medicine en_US
dc.description.abstract To search whether or not the severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccine affects the fertility of women at the 6th months by using AMH, which is an ovarian reserve test. Our study, designed as a prospective case-control study, included 104 women who presented to the GOP EAH obstetrics and gynecology outpatient clinic in January and February 2022. The study group included 74 women who presented to the outpatient clinic and planned to be vaccinated and 30 women who refused to be vaccinated as the control group. Anti-COVID-19 antibody levels in all participants were checked before participation in the study, and participants who were positive were excluded from the study. Blood was taken from the participants in both control and study groups to evaluate their AMH levels before the 2 doses of vaccination. After 2 doses of the vaccine, they were called for follow-up, and serological tests were performed to check whether they were positive for anti-COVID-19 antibodies. Participants in both groups were referred for follow-up after 6 months, samples were taken again for AMH, and the data were recorded. The mean age of the study group was 27.6 +/- 5.3 years, and the mean age of the control group was 28.65 +/- 5.25 years (P = .298). There was no statistically significant difference between the vaccinated and nonvaccinated groups in terms of AMH levels measured at the 6th month (P = .970). When the vaccinated group was compared in terms of AMH values at the first visit before vaccination and at the 6th month after vaccination, no statistically significant difference was found between them (p:0.127) mRNA vaccination to protect against SARS-CoV-2 does not adversely affect ovarian reserve, which is an indirect indicator of fertility. mRNA vaccines continue to be the most important method of protection against epidemics. Carefully and accurately informing women who are hesitant to get vaccinated is of great importance for the success of the fight against the epidemic. en_US
dc.language.iso eng en_US
dc.publisher LIPPINCOTT WILLIAMS & WILKINS-PHILADELPHIA en_US
dc.relation.isversionof 10.1097/MD.0000000000033824 en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject anti-mullerian hormone, fertility, mRNA vaccine, ovarian reserve, SARS-CoV-2 en_US
dc.subject COVID-19 en_US
dc.title Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve? en_US
dc.type article en_US
dc.relation.journal MEDICINE en_US
dc.contributor.department Ordu Üniversitesi en_US
dc.contributor.authorID 0000-0001-8396-5542 en_US
dc.contributor.authorID 0000-0002-0093-2743 en_US
dc.identifier.volume 102 en_US
dc.identifier.issue 20 en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account